Evidence map›Paper›PMID 34728638›Full record

ArticleNature communications2021

Author Correction: PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein.

Min Thura, Abdul Qader Al-Aidaroos, Abhishek Gupta, Cheng Ean Chee, Soo Chin Lee, Kam Man Hui, Jie Li, Yeoh Khay Guan, Wei Peng Yong, Jimmy So and 19 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

29 authors.

Min Thura *Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), Singapore, 138673, Singapore.
Abdul Qader Al-Aidaroos *Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), Singapore, 138673, Singapore.ORCID http://orcid.org/0000-0003-0330-6606
Abhishek GuptaInstitute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), Singapore, 138673, Singapore.
Cheng Ean CheeDepartment of Haematology-Oncology, National University Cancer Institute, Singapore (NCIS), Singapore, 119082, Singapore.
Soo Chin LeeDepartment of Haematology-Oncology, National University Cancer Institute, Singapore (NCIS), Singapore, 119082, Singapore.
Kam Man HuiDivision of Cellular and Molecular Research, National Cancer Centre Singapore, Singapore, 169610, Singapore.
Jie LiInstitute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), Singapore, 138673, Singapore.
Yeoh Khay GuanDepartment of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 119260, Singapore.
Wei Peng YongDepartment of Haematology-Oncology, National University Cancer Institute, Singapore (NCIS), Singapore, 119082, Singapore.
Jimmy SoDivision of Surgical Oncology, National University Cancer Institute, Singapore (NCIS), Singapore, 119082, Singapore.
Wee Joo ChngDepartment of Haematology-Oncology, National University Cancer Institute, Singapore (NCIS), Singapore, 119082, Singapore.
Chin Hin NgDepartment of Haematology-Oncology, National University Cancer Institute, Singapore (NCIS), Singapore, 119082, Singapore.
Jianbiao ZhouDepartment of Haematology-Oncology, National University Cancer Institute, Singapore (NCIS), Singapore, 119082, Singapore.ORCID http://orcid.org/0000-0002-5679-671X
Ling Zhi WangCancer Science Institute of Singapore, National University of Singapore, Singapore, 117599, Singapore.
John Shyi Peng YuenDepartment of Urology, Singapore General Hospital, Singapore, 169608, Singapore.
Henry Sun Sien HoDepartment of Urology, Singapore General Hospital, Singapore, 169608, Singapore.
Sim Mei YiDepartment of Urology, Singapore General Hospital, Singapore, 169608, Singapore.ORCID http://orcid.org/0000-0001-6546-4699
Edmund ChiongDivision of Surgical Oncology, National University Cancer Institute, Singapore (NCIS), Singapore, 119082, Singapore.
Su Pin ChooDivision of Medical Oncology, National Cancer Centre Singapore, Singapore, 169610, Singapore.
Joanne NgeowInstitute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), Singapore, 138673, Singapore.
Matthew Chau Hsien NgDivision of Medical Oncology, National Cancer Centre Singapore, Singapore, 169610, Singapore.
Clarinda ChuaDivision of Medical Oncology, National Cancer Centre Singapore, Singapore, 169610, Singapore.
Eugene Shen Ann YeoDepartment of Colorectal Surgery, Singapore General Hospital, Singapore, 169608, Singapore.
Iain Bee Huat TanDivision of Medical Oncology, National Cancer Centre Singapore, Singapore, 169610, Singapore.
Joel Xuan En SngInstitute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), Singapore, 138673, Singapore.
Nicholas Yan Zhi TanInstitute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), Singapore, 138673, Singapore.
Jean Paul ThieryInstitute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), Singapore, 138673, Singapore.
Boon Cher GohDepartment of Haematology-Oncology, National University Cancer Institute, Singapore (NCIS), Singapore, 119082, Singapore.
Qi ZengInstitute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), Singapore, 138673, Singapore. mcbzengq@imcb.a-star.edu.sg.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID34728638
PMCPMC8564534

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.